King’s Health Partners Experimental Cancer Medicine Centre (ECMC) and Guy’s and St Thomas’ NHS Foundation Trust are piloting software which uses AI to match cancer patients with clinical trials.
The pair have teamed up to use Inspirata’s Trial Navigator software, which bases its matches on patient pathology reports, clinical data, and biomarkers.
The pilot is part of an evaluation into how artificial intelligence-based automation can be used to improve the identification and efficiency of matching cancer patients with early phase clinical trials.
Danny Ruta clinical artificial intelligence lead at Guy’s and St Thomas’ NHS Foundation Trust, said: “AI technology offers the potential to better match our patients to available trials, but we need to evaluate them first to prove that they can deliver on their promise.
“We hope that the intelligent automation afforded by Trial Navigator will prove to be an effective solution for identifying greater numbers of our eligible cancer patient population for clinical trials.”
Trial Navigator has been designed to improve clinical trial matching and supports both the clinician at the point of care and trial coordinators. The software can also be used to carry out instantaneous lookups against relevant trial databases.
Oenone Duroe, general manager for Inspirata Europe, added: “We could not be more excited nor proud to work with Guy’s and St Thomas’, Kings Health Partners and ECMC on this project. We look forward to collaborating closely with the team to validate the efficacy of AI in a clinical trial matching context, and by drawing on insights derived, support equivalent Trial Navigator engagements within the National Health Service.”